Symrise : Q2 growth of 12.1% slightly better vs 11.2% cons.; H1 EBITDA in line; outlook unchanged, just confirming consensus and may disappoint optimists
>Organic growth of 12.1% y-o-y slightly ahead of consensus of 11.2% - Symrise reported group sales of € 1,274m in Q2 2024, in line with consensus of € 1,270m (ODDO BHF € 1,245m) and up 8% y-o-y as 4% forex headwind weighed on performance. Organic growth of 12.1% y-o-y was slightly ahead of consensus of 11.2% (ODDO BHF 9.4%) and compared to the Q1 2024 level of 10.9% and against an undemanding comparison base in Q2 2023 at S&C.The taste, nutrition & health...Symrise AG develops, produces, and sells fragrances and flavors as well as active ingredients for the cosmetics industry. Co. operates in two main business segments: The Scent & Care segment, which develops, produces and sells fragrances, cosmetic ingredients, aroma molecules and mint aromas and also develops specific application processes for such substances; and The Flavor & Nutrition segment, which develops, produces and sells flavors that are used by customers in the production of food products (savory and sweet food products as well as dairy products) and beverages.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.